|
|
|||||||||||
Psychopharmacology Unit, University of Bristol, Bristol, and MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Psychopharmacology Unit, University of Bristol, and Bristol Specialist Drug Service, Bristol, and MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Psychopharmacology Unit, University of Bristol, Bristol, UK
Psychopharmacology Unit, University of Bristol, Bristol, and MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Unit of Biochemistry and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Hospital of Cery, Prilly, Switzerland
Laboratory of Forensic Toxicology and Chemistry, Institute of Forensic Medicine, CHUV, Lausanne, Switzerland
MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Bristol Specialist Drug Service, Stokes Croft, Bristol, UK
MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Psychopharmacology Unit, University of Bristol, Bristol, and MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK
Psychopharmacology Unit, University of Bristol, Bristol, UK
Correspondence: Professor David J. Nutt, Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK. Email: david.j.nutt{at}bristol.ac.uk
None. Funding detailed in Acknowledgements.
Background
Drugs of dependence cause dopamine release in the rat striatum. Human neuroimaging studies have shown an increase in dopamine in the equivalent region in response to stimulants and other drugs.
Aims
We tested whether opioids provoke dopamine release and its relationship to the subjective experience.
Method
In two combined studies 14 heroin addicts on methadone maintenance treatment underwent two positron emission tomography brain scans of the dopamine system using [11C]-raclopride following an injection of placebo and either 50 mg intravenous diamorphine or 10 mg subcutaneous hydromorphone in a double-blind, random order design.
Results
Both opioids produced marked subjective and physiological effects, but no measurable change in [11C]-raclopride binding.
Conclusions
The absence of a dopamine response to opioid agonists contrasts with that found with stimulant drugs and suggests dopamine may not play the same role in addiction to opioids. This questions the role of dopamine in the subjective experience of heroin in opioid addicts.
Related articles in BJP:
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |